This work demonstrates efficient butanediols production from erythritol using ReO x /TiO 2 catalysts, suggesting potential for polymer synthesis.
This work reports the use of non noble monometallic heterogeneous catalysts for the efficient hydrodeoxygenation of erythritol (ERY) toward butanediols in aqueous media. ERY is a biosourced polyols of growing interest, as it can be selectively converted into valuable C 4 molecules, particularly butanediols (BDO), which are key building blocks for polymer synthesis. However, achieving high BDO selectivity remains challenging due to the complex reaction network leading to multiple by‐products. The catalysts developed in this study consist of rhenium nanoparticles supported on titania materials with different crystallographic phases. These ReO x /TiO 2 catalysts were prepared by wet impregnation and thoroughly characterized using inductively coupled plasma optical emission spectroscopy, XRD, thermogravimetric analysis, XPS, STEM, H 2 ‐TPR, and NH 3 ‐TPD to elucidate the influence of TiO 2 crystallinity on rhenium dispersion, reducibility, acidity, metal–support interactions, and catalytic behavior. Among the tested materials, ReO x /TiO 2 based on mixed‐phase TiO 2 (P25, anatase–rutile) exhibited optimal physicochemical properties, enabling efficient CO bond cleavage. Under 240°C and 60 bar H 2 , it achieved 98% ERY conversion with 55% selectivity toward BDO after 6 h. Mechanistic investigations revealed that the catalyst promotes simultaneous removal of vicinal hydroxyl groups through deoxydehydration, accounting for the high selectivity toward 1,2‐BDO. Continuous‐flow tests demonstrated excellent stability without rhenium leaching.
No takes yet. Share an insight, caveat, or question.
Bayeh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: